Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
245 EUR | -0.22% |
|
+4.29% | -14.54% |
01:27pm | Genmab, J&J Log Higher Q2 Sales for Blood Cancer Drug Darzalex | MT |
Jul. 15 | RBC Capital Upgrades Genmab to Outperform | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- GMAB Stock
- GE9 Stock
- Revisions Genmab A/S